About this trial
The goal of this clinical trial is to learn if a treatment for adults with PTSD called prolonged exposure + incentives (PE+) works to treat pregnant patients. The main question it aims to answer is:
Does PE+ decrease PTSD symptoms?
All participants will receive PE+ to see if their PTSD symptoms at the end of the trial are less than at the beginning.
Participants will:
* Receive individual PE+ therapy for 1 hour weekly for 12 weeks. * Receive financial incentives for attending each PE+ session. * Attend assessment visits every 4 weeks for the 12 weeks of the trial. * Allow research staff to collect some information about their labor and delivery from their medical records after their babies are born.
Eligibility criteria
Qualifiers
Female
>18 years old
Gestational age ≤ 25 weeks
Meet current DSM-5 posttraumatic stress disorder criteria based on the Clinician Administered PTSD Scale for DSM-5
Disqualifiers
Male
Under 18 years old
Gestational age > 25 weeks
No current diagnosis of PTSD
Trial design
Treatments tested in this trial
- Prolonged exposure therapy + incentives for therapy session attendance